期刊文献+

氟喹诺酮类与万古霉素治疗皮肤感染的临床效果研究 被引量:3

Clinical effect of fluoroquinolones and vancomycin in treatment of skin infections
原文传递
导出
摘要 目的观察对中重度急性无合并症的复杂性皮肤感染中氟喹诺酮类与万古霉素治疗的临床效果,探讨氟喹诺酮类与万古霉素治疗皮肤感染的细菌清除率。方法选择2012年2月-2013年2月医院收治的148例中重度皮肤感染患者,按GCP要求签署知情同意书,随机平均分为观察组和对照组各74例,对照组患者均根据药物适应证常规给氟喹诺酮类药物,观察组在此基础上联合万古霉素治疗,观察对比两组临床疗效,采用总体统计方法,连续数据用t检验,分类数据用F检验。结果治疗结束第1天,观察组临床有效率为83.78%,明显优于对照组的67.57%;治疗第7天,观察组临床有效率为20.27%,明显优于对照组的17.57%;治疗结束第1天细菌清除率观察组100.00%、对照组91.89%,两组比较差异无统计学意义,治疗第7天细菌清除率观察组62.16%、对照组51.35%,两组比较差异无统计学意义。结论对中重度急性无合并症的复杂性皮肤感染,在单纯应用氟喹诺酮类抗菌药物达不到理想疗效时,可谨慎联合万古霉素治疗,不失是一个最佳的治疗措施。 OBJECTIVE To explore the moderate to severe acute uncomplicated complex skin infections by using fluoroquinolones and vancomycin; and explore the bacterial clearance rate of fluoroquinolones and vancomycin in treatment on skin infections. METHODS A total of 148 cases of patients with moderate to severe skin infections admitted to the hospital from Feb 2012 to Feb 2013 were selected. After signing an informed consent form accord- ing to GCP requirements, they were randomly divided into an observation group and a control group, each consis- ting of 74 patients. The patients in the control group were given conventional fluoroquinolones according to indica- tions of drugs; the patients in the observation group were given vancomycin on the same basis. The clinical effica- cy was observed and contrasted, making use of general statistical methods, with the t test for continuous data and F test for categorical data. RESULTS At the end of the first day of treatment, the clinical effective rate of the observation group was 83.78%, significantly better than 67.57% in the control group% on the seventh day of treatment, the clinical effective rate of the observation group was 20.27%, significantly better than 17.57% in the control group. By the first day at the end of treatment, the bacterial clearance rate of the observation group was 100.00 %, with 91. 89% in the control group, thus no significant difference was observed for the two groups. On the seventh day of treatment, the bacterial clearance rate of the observation group was 62.26 %, with 51.53% in the control group, thus no significant difference was observed for the two groups. CONCLUSION As to moderate to severe acute uncomplicated complex skin infections, in case that simple application of fluoroquinolone antibiotics can not reach the desired effect, it can be carefully combined with vancomycin, which can be regarded as the best treatment measure.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第8期1882-1884,共3页 Chinese Journal of Nosocomiology
基金 青海省科技厅自然基金资助项目(2013-Z-731)
关键词 氟喹诺酮类 万古霉素 皮肤感染 Fluoroquinolones Vancomycin Skin infections
  • 相关文献

参考文献6

二级参考文献19

  • 1International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Classification of Staphylococcal Cassette Chromosome mec (SCC- mec) : Guidelines for Reporting Novel SCCmec Elements[J]. Antimicrob Agents Chemother, 2009,53(12): 4961-4967.
  • 2Ito T,Ma XX,Takeuchi F,et al. Novel type V staphylococ- cal cassette chromosome mec driven by a novel cassette chromosome reeombinase, ccrC[J]. Antimicrob Agents Chemother,2004,48(7) :2637-2651.
  • 3Katayama Y, Takeuchi F, Ito T, et al. Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mohile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus[J]. J Bacteriol, 2003,185 (9) : 2711-2722.
  • 4Jonas D, Grundmann H, Hartung D, et al. Evaluation of the mecA femB duplex polymerase chainReaction for detection of methicillin-resistant Staphylococcus aureus [J]. Eur J Clin Microbiol Infect Dis, 1999,18(9): 643-647.
  • 5Zhang K, McClure JA, Elsayed S, et al. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcus cassette chromosome mec Types I to V in methicillin-resistant Staphylococcus aureus[J]. J Clin Microbiol, 2005,43 (10) : 5026-5033.
  • 6Oliveira DC,Lencastre H. Multiplex PCR strategy for rapid identification of structural Types and Variants of.the mec element in methicillin-resistant Staphylococcus aureus[J]. Antimicrobial agents and chemotherapy, 2002,46 (7): 2155-2161.
  • 7Gerard L, Piemont Y, Godail-Gamot F, et al. Involvement of panton-valentine Ieukocidin-producing Staphylococcus aureusin primary skirt infections and pneumonia[J]. Clinical Infectious Diseases,1999,29(5):1128-1132.
  • 8Deurenberg RH,Vink C, Oudhuis GJ, et al. Different clonal complexes of Methicillin resistant Staphylococcus aureus are disseminated in the euregio meuse-rhine region[J]. Antimicrob Agents Chemother,2005,49(10) :4263-4271.
  • 9Dutka M,Evers S,Courvalin L.Detection of glycopeptidesresistance genotypes and idemification to the species level ofclinically relevant Enterococci by PCR[J].J Clin Microbiol,l995,33(1):24-27.
  • 10Centers for disease control and prevention.Investigation andcontrol of vancomycin-intermediate and resistant Staphylo-coccus aureus:aguide for health department and infectioncontrol personnel[J].Atlanta,GA.2003.

共引文献135

同被引文献32

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部